等待开盘 08-05 09:30:00 美东时间
+1.370
+2.09%
Merus N.V. granted 240,000 stock options to two new employees on August 1, 2025, as an inducement award outside its 2016 Incentive Award Plan. The options have an exercise price of $65.56 per share, a ten-year term, and vest over four years. The Board of Directors and independent directors approved the grant based on the Compensation Committee’s recommendation. The awards are subject to continuous service and the Plan’s terms.
08-04 20:01
近日,贝达药业收到国家药品监督管理局(以下简称“NMPA”)签发的《受理通知书》(受理号:CXSL2500542、CXHL2500646、CXHL250064...
08-01 04:37
7月29日,贝达药业注射用MCLA-129在肺癌领域开展的一项关于驱动基因阳性以及MET扩增相关的II期研究完成首例患者入组。 该研究全称为“一项评价抗EGF...
07-29 18:57
Mercury Systems Inc. will release its fourth quarter and full year fiscal year 2025 financial results on August 11, 2025, after market close. Management will host a conference call and webcast at 5:00 p.m. ET on the same day to discuss the financial results, business highlights, and outlook. Participants can register online in advance or at least 15 minutes before the call at [ir.mrcy.com/events-presentations](https://www.globenewswire.com/Tracke...
07-21 20:15
Merus Power has completed and put into operation an energy storage facility in Lappeenranta, Finland. The facility, jointly owned by Ardian’s Clean Energy Evergreen Fund and Lappeenrannan Energia, is one of the largest in Finland with a capacity of 38 MW and 43 MWh. Kari Tuomala, CEO of Merus Power, highlighted the company's expertise in delivering comprehensive energy storage solutions. The facility contributes to grid stability and supports Fin...
07-03 07:00
Merus NV (($MRUS)) announced an update on their ongoing clinical study. Merus N...
06-27 00:27
Merus N.V. (NASDAQ:MRUS) on Tuesday announced the launch of a proposed underwritten public offering of its common shares. All of the common shares are being offered by Merus. In addition, Merus expec...
06-04 04:25
Merus N.V. is launching a proposed underwritten public offering of its common shares to advance clinical development, preclinical research, and general corporate purposes. The offering may include an additional 15% of shares. The offering is subject to market and other conditions. Merus plans to use proceeds for its clinical development and research.
06-03 20:05
(转自:药剂Talks) 恒瑞医药又在国际舞台上亮剑了。 美国临床肿瘤学会(ASCO)年会是全球规模最大、学术水平最高且最具权威性的临床肿瘤学盛会,吸引了全球...
06-02 08:53
11 mid-cap stocks soared last week, including LZ Technology, Centrus Energy, e.l.f Beauty, Merus, Oklo, NuScale Power, Informatica, BRP, Box, Joby Aviation, and C3.ai.
06-01 22:00